Xinling Ren

984 total citations
31 papers, 735 citations indexed

About

Xinling Ren is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinling Ren has authored 31 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinling Ren's work include MicroRNA in disease regulation (5 papers), Reproductive Biology and Fertility (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Xinling Ren is often cited by papers focused on MicroRNA in disease regulation (5 papers), Reproductive Biology and Fertility (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Xinling Ren collaborates with scholars based in China, United States and Hong Kong. Xinling Ren's co-authors include Hong Yin, Changgui Wu, Tao Zhang, Xinyu Ti, Jian Zhang, Zhikui Li, Rui Zhang, Angang Yang, Yan Li and Qing Miao and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Biomaterials.

In The Last Decade

Xinling Ren

31 papers receiving 729 citations

Peers

Countries citing papers authored by Xinling Ren

Since Specialization

Citations

This map shows the geographic impact of Xinling Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinling Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinling Ren more than expected).

Fields of papers citing papers by Xinling Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinling Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinling Ren. The network helps show where Xinling Ren may publish in the future.

Co-authorship network of co-authors of Xinling Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xinling Ren. A scholar is included among the top collaborators of Xinling Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinling Ren. Xinling Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The density of the inner cell mass is a new indicator of the quality of a human blastocyst: a valid supplement to the Gardner scoring system 2024 ·Human Reproduction ·Bo Huang, Li Zhou, Xinling Ren, (unknown), Jing Yue, Xiyuan Dong, Liu Yang, (unknown), Jinzhong Wang, (unknown), Xuefeng Wang, (unknown), (unknown), Zhenzhi Shi, Lei Jin	2
2	Intermittent short-duration reoxygenation relieves high-altitude pulmonary hypertension via NOX4/H2O2/PPAR-γ axis 2024 ·Clinical Science ·(unknown), (unknown), Qixin Shi, Yungang Bai, Xinling Ren, Jin Ma	5
3	Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases 2024 ·Journal of Nanobiotechnology ·Jun Jiang, Yuan Lu, Jie Chu, Xiao Zhang, (unknown), Shaojie Liu, Zhuo Wan, Jiawei Wang, Lu Zhang, Kui Liu, (unknown), Angang Yang, Xinling Ren, Rui Zhang	22
4	GVBD rate is an independent predictor for pregnancy in ICSI patients with surplus immature oocytes 2023 ·Frontiers in Endocrinology ·Meng Wang, Qiyu Yang, (unknown), Juan Hu, Dan Li, Xinling Ren, Qingsong Xi, Lixia Zhu, Lei Jin	1
5	ALK inhibitors in ALK-rearranged non-small cell lung cancer with and without brain metastases: systematic review and network meta-analysis 2022 ·BMJ Open ·Jun Jiang, (unknown), Fang Zhang, (unknown), Kaiyuan Zhou, Xinling Ren, Yi Wan	10
6	Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma 2022 ·BMC Cancer ·Jun Jiang, (unknown), Fang Zhang, Tao Pan, Zhipei Zhang, Yi Ching Esther Wan, Xinling Ren, Rui Zhang	11
7	Semaphorins as Potential Immune Therapeutic Targets for Cancer 2022 ·Frontiers in Oncology ·Jun Jiang, Fang Zhang, (unknown), Ke Fang, Zedong Yan, Xinling Ren, Rui Zhang	8
8	Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve 2022 ·BMC Genomics ·Chang Liu, (unknown), Bo Yang, Yiqing Zhao, Xiyuan Dong, Lixia Zhu, Xinling Ren, Bo Huang, Jing Yue, Lei Jin, Hanwang Zhang, Lan Wang	14
9	β-Hydroxyisovalerylshikonin regulates macrophage polarization via the AMPK/Nrf2 pathway and ameliorates sepsis in mice 2022 ·Pharmaceutical Biology ·Tao Pan, (unknown), Min He, Zehui He, Jun Jiang, Xinling Ren, Fang Zhang	14
10	EGFR-specific single-chain variable fragment antibody-conjugated Fe3O4/Au nanoparticles as an active MRI contrast agent for NSCLC 2021 ·Magnetic Resonance Materials in Physics Biology and Medicine ·Yuan Lu, Jing Huang, (unknown), Yuan Wang, (unknown), Jian Zhang, Hong Yin, Rui Zhang, Xinling Ren	17
11	The Emerging Roles of Long Noncoding RNAs as Hallmarks of Lung Cancer 2021 ·Frontiers in Oncology ·Jun Jiang, Yuan Lu, Fang Zhang, Jie Huang, Xinling Ren, Rui Zhang	18
12	The Causes and Consequences of miR-503 Dysregulation and Its Impact on Cardiovascular Disease and Cancer 2021 ·Frontiers in Pharmacology ·(unknown), Yin Cai, Pearl Pai, Xinling Ren, Zhengyuan Xia	14
13	Intermittent short‐duration reoxygenation protects against simulated high altitude‐induced pulmonary hypertension in rats 2020 ·The FASEB Journal ·(unknown), Yungang Bai, (unknown), Huan Liu, Shaohua Li, Jing Yang, (unknown), Yan Ma, Min Jiang, Dong Dong, (unknown), Qixin Shi, Xinling Ren, Jin Ma	11
14	Identification of differentially expressed genes and signaling pathways using bioinformatics in interstitial lung disease due to tyrosine kinase inhibitors targeting the epidermal growth factor receptor 2018 ·Investigational New Drugs ·Yuan Lü, Ang Li, Xiaofeng Lai, Jun Jiang, Lihong Zhang, Zhicheng Zhong, (unknown), Ping Tang, Hu Zhao, Xinling Ren	8
15	ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance 2016 ·Oncotarget ·Mingxiang Ye, Xinxin Zhang, Nan Li, Yong Zhang, Pengyu Jing, Ning Chang, Jianxiong Wu, Xinling Ren, Jiän Zhang	25
16	HER2-siRNA delivered by EGFR-specific single chain antibody inhibits NSCLC cell proliferation and tumor growth 2016 ·Oncotarget ·(unknown), Yuan Wang, (unknown), (unknown), (unknown), Jian Zhang, Mingxiang Ye, Hu Zhao, Jing Zhao, Bo Yan, Angang Yang, Rui Zhang, Xia Li, Xinling Ren	9
17	Rapidly Progressive Diffuse Cystic Lesions as a Radiological Hallmark of Lung Adenocarcinoma 2012 ·Journal of Thoracic Oncology ·Jian Zhang, Yilin Zhao, (unknown), (unknown), Hua Wu, Changgui Wu, Xinling Ren, Jian Wen	10
18	HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells 2011 ·Gastroenterology ·Wei Bao, Haijing Fu, (unknown), Lei Wang, Rui Zhang, Zhangyan Guo, Jing Zhao, Yan–Ling Meng, Xinling Ren, Tao Wang, Qing Li, Boquan Jin, Libo Yao, Rui‐An Wang, Daiming Fan, Si–Yi Chen, Lintao Jia, Angang Yang	138
19	Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu 2009 ·Cancer Letters ·Xinling Ren, Yan‐Ming Xu, (unknown), Haijing Fu, Changgui Wu, Ying Zhao, Zhikui Li, Jiän Zhang, Shengqing Li, Weiqiang Chen, Tao Wang, Rui Zhang, Lihong Zhang, Guisheng Qian, Si–Yi Chen, Lintao Jia, Angang Yang	12
20	Blockade of AT₁ receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats 2008 ·Journal of Applied Physiology ·Ran Zhang, Yungang Bai, Lejian Lin, Junxiang Bao, Yuyang Zhang, Hao Tang, (unknown), Guoliang Jia, Xinling Ren, Jin Ma	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact